Webcast link to Corporate Update Conference Call on Thursday, May 29, 2025 at 8:30 a.m.

Bio-Path Holdings to Host Corporate Update Conference Call on May 29, 2025

BPTH_Corporate_Update_Conference_Call_Announcement_20250522

SEC Form 10-Q: For Period ending March 31, 2025

BPTH_20250515_10-Q

SEC Form 8-K: Press Release dated May 1, 2025

BPTH_8-K_20250502

Bio-Path Holdings Achieves Third Pre-Clinical Milestone Confirming Potential of BP1001-A as Treatment for Obesity in Type 2 Diabetes Patients

BP1001-A_Obesity_Third_Efficacy_Milestone

SEC Form 8-K: Entry into a Material Definitive Agreement

BPTH_8-K_20250429

SEC Form 1-A

BPTH_Form_1-A_20250411

SEC: Withdrawal of Registration Statement on Form S-1

BPTH_25-3664-12__RW_20250409

SEC Form 8-K: Entry into a Material Definitive Agreement

BPTH_8-K_25-10724

SEC Form 8-K: Press Release dated March 28, 2025

BPTH20250327_8-K